NewcelX NCEL
NASDAQ NCEL
$2.97 +0.05 (+1.71%)
As of: Sep 29, 2026 · 3:59 PM EDT

NewcelX (NCEL) Current Leases (2022 - 2024)

Updated

NewcelX (NCEL) posted Current Leases of $144,000 for Q2 2024, down 66.4% from $429,000 a year earlier.

Analysis

NewcelX (NCEL) Current Leases (2022 - 2024) Analysis & Trends

At the end of FY2023, NewcelX's Current Leases came in at $361,000, down 9.1% from FY2022.

  • In prior years, NewcelX's Current Leases was $397,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 NewcelX 11.22 Mn 11.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 144,000.00
Dec 31, 2023 361,000.00
Jun 30, 2023 429,000.00
Dec 31, 2022 397,000.00
API Access

NewcelX Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=NCEL&period=max&api_key=YOUR_API_KEY